[ { "label": "delamanid", "note": "승인 결핵약 · 다른 표적에 작용", "note_en": "approved TB drug, acts on a different target", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 39.164, "axes": { "activity": { "points": 18.8, "detail": { "pAct_q10": 5.022, "threshold_passed": true, "threshold_term": 1.0, "ramp_term": 0.88, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 10.223, "detail": { "pIC50": 6.56, "LE": 0.236, "potency_term": 0.519, "efficiency_cap": 0.788, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 1.749, "detail": { "fold": 1.9, "selectivity_term": 0.135, "target_engagement": 0.519 } }, "admet": { "points": 4.884, "detail": { "geometric_mean": 0.346, "per_endpoint": { "solubility-aqsoldb": 0.132, "caco2-wang": 0.531, "hia-hou": 1.0, "bioavailability-ma": 0.951, "pgp-broccatelli": 0.05, "cyp2c9-veith": 0.285, "cyp3a4-substrate-carbonmangels": 0.226, "ld50-zhu": 0.563, "herg": 0.05, "dili": 0.55 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 3.508, "detail": { "sa_score": 3.39 } } } }, { "label": "prothionamide", "note": "전구약 — 체내에서 바뀌어야 작용한다", "note_en": "prodrug - has to be converted inside the cell to work", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 33.203, "axes": { "activity": { "points": 16.169, "detail": { "pAct_q10": 4.737, "threshold_passed": true, "threshold_term": 1.0, "ramp_term": 0.617, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 2.095, "detail": { "pIC50": 4.93, "LE": 0.563, "potency_term": 0.084, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 0.6, "selectivity_term": 0.0, "target_engagement": 0.0 } }, "admet": { "points": 10.897, "detail": { "geometric_mean": 0.899, "per_endpoint": { "solubility-aqsoldb": 0.945, "caco2-wang": 1.0, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.664, "herg": 1.0, "dili": 0.511 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 4.042, "detail": { "sa_score": 2.23 } } } }, { "label": "ethionamide", "note": "전구약 — 체내에서 바뀌어야 작용한다", "note_en": "prodrug - has to be converted inside the cell to work", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 31.53, "axes": { "activity": { "points": 15.757, "detail": { "pAct_q10": 4.693, "threshold_passed": true, "threshold_term": 1.0, "ramp_term": 0.576, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 1.542, "detail": { "pIC50": 4.81, "LE": 0.599, "potency_term": 0.062, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 0.4, "selectivity_term": 0.0, "target_engagement": 0.0 } }, "admet": { "points": 10.292, "detail": { "geometric_mean": 0.871, "per_endpoint": { "solubility-aqsoldb": 1.0, "caco2-wang": 1.0, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.607, "herg": 1.0, "dili": 0.342 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 3.939, "detail": { "sa_score": 2.25 } } } }, { "label": "pretomanid", "note": "승인 결핵약 · 다른 표적에 작용", "note_en": "approved TB drug, acts on a different target", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 30.922, "axes": { "activity": { "points": 10.853, "detail": { "pAct_q10": 4.163, "threshold_passed": true, "threshold_term": 1.0, "ramp_term": 0.085, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 11.78, "detail": { "pIC50": 6.41, "LE": 0.351, "potency_term": 0.471, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 0.6, "selectivity_term": 0.0, "target_engagement": 0.471 } }, "admet": { "points": 4.444, "detail": { "geometric_mean": 0.546, "per_endpoint": { "solubility-aqsoldb": 0.328, "caco2-wang": 0.801, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 0.55, "cyp3a4-substrate-carbonmangels": 0.53, "ld50-zhu": 0.337, "herg": 1.0, "dili": 0.05 } } }, "novelty": { "points": 1.753, "detail": { "max_tanimoto": 0.677, "novelty": 0.323 } }, "synthesis": { "points": 2.092, "detail": { "sa_score": 3.3 } } } }, { "label": "clofazimine", "note": "승인 결핵약 · 다른 표적에 작용", "note_en": "approved TB drug, acts on a different target", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 29.609, "axes": { "activity": { "points": 19.116, "detail": { "pAct_q10": 5.056, "threshold_passed": true, "threshold_term": 1.0, "ramp_term": 0.912, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.818, "detail": { "pIC50": 4.72, "LE": 0.196, "potency_term": 0.05, "efficiency_cap": 0.654, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 0.2, "selectivity_term": 0.0, "target_engagement": 0.0 } }, "admet": { "points": 4.919, "detail": { "geometric_mean": 0.343, "per_endpoint": { "solubility-aqsoldb": 0.05, "caco2-wang": 0.77, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 0.05, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.262, "herg": 0.05, "dili": 0.424 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 4.756, "detail": { "sa_score": 2.52 } } } }, { "label": "linezolid", "note": "승인 결핵약 · 다른 표적에 작용", "note_en": "approved TB drug, acts on a different target", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 22.924, "axes": { "activity": { "points": 11.027, "detail": { "pAct_q10": 4.182, "threshold_passed": true, "threshold_term": 1.0, "ramp_term": 0.103, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 2.763, "detail": { "pIC50": 5.33, "LE": 0.304, "potency_term": 0.111, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.939, "detail": { "fold": 4.8, "selectivity_term": 0.34, "target_engagement": 0.111 } }, "admet": { "points": 5.642, "detail": { "geometric_mean": 0.682, "per_endpoint": { "solubility-aqsoldb": 0.864, "caco2-wang": 0.891, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.26, "herg": 0.357, "dili": 0.225 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 2.553, "detail": { "sa_score": 2.76 } } } }, { "label": "moxifloxacin", "note": "승인 결핵약 · 다른 표적에 작용", "note_en": "approved TB drug, acts on a different target", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 22.759, "axes": { "activity": { "points": 12.592, "detail": { "pAct_q10": 4.351, "threshold_passed": true, "threshold_term": 1.0, "ramp_term": 0.259, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 1.862, "detail": { "pIC50": 4.98, "LE": 0.235, "potency_term": 0.095, "efficiency_cap": 0.784, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 0.4, "selectivity_term": 0.0, "target_engagement": 0.0 } }, "admet": { "points": 6.064, "detail": { "geometric_mean": 0.642, "per_endpoint": { "solubility-aqsoldb": 0.611, "caco2-wang": 0.561, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 0.767, "ld50-zhu": 0.538, "herg": 1.0, "dili": 0.05 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 2.241, "detail": { "sa_score": 3.51 } } } }, { "label": "bedaquiline", "note": "승인 결핵약 · 다른 표적에 작용", "note_en": "approved TB drug, acts on a different target", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 21.329, "axes": { "activity": { "points": 14.215, "detail": { "pAct_q10": 4.526, "threshold_passed": true, "threshold_term": 1.0, "ramp_term": 0.421, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.94, "detail": { "pIC50": 4.82, "LE": 0.178, "potency_term": 0.063, "efficiency_cap": 0.594, "heavy_halogens": 1, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 0.2, "selectivity_term": 0.0, "target_engagement": 0.0 } }, "admet": { "points": 3.532, "detail": { "geometric_mean": 0.331, "per_endpoint": { "solubility-aqsoldb": 0.05, "caco2-wang": 0.662, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 0.05, "cyp2c9-veith": 0.788, "cyp3a4-substrate-carbonmangels": 0.05, "ld50-zhu": 0.993, "herg": 0.05, "dili": 0.596 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 2.642, "detail": { "sa_score": 3.4 } } } }, { "label": "isoniazid", "note": "전구약 — 체내에서 바뀌어야 작용한다", "note_en": "prodrug - has to be converted inside the cell to work", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 21.263, "axes": { "activity": { "points": 11.517, "detail": { "pAct_q10": 4.235, "threshold_passed": true, "threshold_term": 1.0, "ramp_term": 0.152, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.244, "detail": { "pIC50": 4.07, "LE": 0.558, "potency_term": 0.01, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 1.3, "selectivity_term": 0.049, "target_engagement": 0.0 } }, "admet": { "points": 6.623, "detail": { "geometric_mean": 0.767, "per_endpoint": { "solubility-aqsoldb": 1.0, "caco2-wang": 0.906, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.305, "herg": 1.0, "dili": 0.244 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 2.879, "detail": { "sa_score": 1.9 } } } }, { "label": "levofloxacin", "note": "승인 결핵약 · 다른 표적에 작용", "note_en": "approved TB drug, acts on a different target", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 20.736, "axes": { "activity": { "points": 10.545, "detail": { "pAct_q10": 4.13, "threshold_passed": true, "threshold_term": 1.0, "ramp_term": 0.055, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 3.028, "detail": { "pIC50": 5.38, "LE": 0.284, "potency_term": 0.128, "efficiency_cap": 0.946, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.26, "detail": { "fold": 1.5, "selectivity_term": 0.081, "target_engagement": 0.128 } }, "admet": { "points": 4.717, "detail": { "geometric_mean": 0.596, "per_endpoint": { "solubility-aqsoldb": 0.897, "caco2-wang": 0.962, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.107, "herg": 1.0, "dili": 0.05 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 2.186, "detail": { "sa_score": 3.1 } } } }, { "label": "ibuprofen", "note": "결핵과 무관 (음성 대조)", "note_en": "nothing to do with tuberculosis (negative control)", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 1.639, "axes": { "activity": { "points": 0.286, "detail": { "pAct_q10": 3.144, "threshold_passed": false, "threshold_term": 0.019, "ramp_term": 0.01, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.705, "detail": { "pIC50": 4.49, "LE": 0.41, "potency_term": 0.028, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 3.2, "selectivity_term": 0.254, "target_engagement": 0.0 } }, "admet": { "points": 0.313, "detail": { "geometric_mean": 0.74, "per_endpoint": { "solubility-aqsoldb": 0.677, "caco2-wang": 1.0, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.212, "herg": 1.0, "dili": 0.528 } } }, "novelty": { "points": 0.194, "detail": { "max_tanimoto": 0.314, "novelty": 0.686 } }, "synthesis": { "points": 0.141, "detail": { "sa_score": 2.19 } } } }, { "label": "cycloserine", "note": "승인약이나 표준 시험에서 약하다", "note_en": "approved, but weak under standard testing", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 1.439, "axes": { "activity": { "points": 0.394, "detail": { "pAct_q10": 3.271, "threshold_passed": false, "threshold_term": 0.026, "ramp_term": 0.014, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.585, "detail": { "pIC50": 4.42, "LE": 0.865, "potency_term": 0.023, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 0.2, "selectivity_term": 0.0, "target_engagement": 0.0 } }, "admet": { "points": 0.206, "detail": { "geometric_mean": 0.587, "per_endpoint": { "solubility-aqsoldb": 1.0, "caco2-wang": 0.369, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.05, "herg": 1.0, "dili": 1.0 } } }, "novelty": { "points": 0.194, "detail": { "max_tanimoto": 0.171, "novelty": 0.829 } }, "synthesis": { "points": 0.06, "detail": { "sa_score": 4.2 } } } }, { "label": "caffeine", "note": "결핵과 무관 (음성 대조)", "note_en": "nothing to do with tuberculosis (negative control)", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 1.404, "axes": { "activity": { "points": 0.586, "detail": { "pAct_q10": 3.431, "threshold_passed": false, "threshold_term": 0.038, "ramp_term": 0.02, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.298, "detail": { "pIC50": 4.15, "LE": 0.406, "potency_term": 0.012, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 2.1, "selectivity_term": 0.163, "target_engagement": 0.0 } }, "admet": { "points": 0.218, "detail": { "geometric_mean": 0.496, "per_endpoint": { "solubility-aqsoldb": 1.0, "caco2-wang": 1.0, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 0.05, "ld50-zhu": 0.096, "herg": 0.1, "dili": 0.58 } } }, "novelty": { "points": 0.156, "detail": { "max_tanimoto": 0.467, "novelty": 0.533 } }, "synthesis": { "points": 0.146, "detail": { "sa_score": 2.3 } } } }, { "label": "para-aminosalicylic acid", "note": "승인약이나 표준 시험에서 약하다", "note_en": "approved, but weak under standard testing", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 1.357, "axes": { "activity": { "points": 0.227, "detail": { "pAct_q10": 3.052, "threshold_passed": false, "threshold_term": 0.015, "ramp_term": 0.008, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.739, "detail": { "pIC50": 4.51, "LE": 0.562, "potency_term": 0.03, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 9.3, "selectivity_term": 0.484, "target_engagement": 0.0 } }, "admet": { "points": 0.243, "detail": { "geometric_mean": 0.549, "per_endpoint": { "solubility-aqsoldb": 1.0, "caco2-wang": 0.246, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 0.815, "ld50-zhu": 0.05, "herg": 1.0, "dili": 1.0 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 0.148, "detail": { "sa_score": 1.88 } } } }, { "label": "metformin", "note": "결핵과 무관 (음성 대조)", "note_en": "nothing to do with tuberculosis (negative control)", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 1.218, "axes": { "activity": { "points": 0.588, "detail": { "pAct_q10": 3.432, "threshold_passed": false, "threshold_term": 0.039, "ramp_term": 0.02, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.093, "detail": { "pIC50": 3.68, "LE": 0.561, "potency_term": 0.004, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 0.3, "selectivity_term": 0.0, "target_engagement": 0.0 } }, "admet": { "points": 0.198, "detail": { "geometric_mean": 0.45, "per_endpoint": { "solubility-aqsoldb": 1.0, "caco2-wang": 0.05, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.05, "herg": 1.0, "dili": 1.0 } } }, "novelty": { "points": 0.241, "detail": { "max_tanimoto": 0.179, "novelty": 0.821 } }, "synthesis": { "points": 0.098, "detail": { "sa_score": 3.67 } } } }, { "label": "pyrazinamide", "note": "승인약이나 표준 시험에서 약하다", "note_en": "approved, but weak under standard testing", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 1.077, "axes": { "activity": { "points": 0.443, "detail": { "pAct_q10": 3.319, "threshold_passed": false, "threshold_term": 0.029, "ramp_term": 0.015, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.326, "detail": { "pIC50": 4.18, "LE": 0.637, "potency_term": 0.013, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 1.6, "selectivity_term": 0.096, "target_engagement": 0.0 } }, "admet": { "points": 0.197, "detail": { "geometric_mean": 0.592, "per_endpoint": { "solubility-aqsoldb": 1.0, "caco2-wang": 0.848, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.104, "herg": 1.0, "dili": 0.05 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 0.111, "detail": { "sa_score": 2.17 } } } }, { "label": "paracetamol", "note": "결핵과 무관 (음성 대조)", "note_en": "nothing to do with tuberculosis (negative control)", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 0.958, "axes": { "activity": { "points": 0.403, "detail": { "pAct_q10": 3.281, "threshold_passed": false, "threshold_term": 0.026, "ramp_term": 0.014, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.174, "detail": { "pIC50": 3.93, "LE": 0.49, "potency_term": 0.007, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 0.8, "selectivity_term": 0.0, "target_engagement": 0.0 } }, "admet": { "points": 0.166, "detail": { "geometric_mean": 0.549, "per_endpoint": { "solubility-aqsoldb": 1.0, "caco2-wang": 1.0, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 0.05, "ld50-zhu": 0.05, "herg": 1.0, "dili": 1.0 } } }, "novelty": { "points": 0.114, "detail": { "max_tanimoto": 0.432, "novelty": 0.568 } }, "synthesis": { "points": 0.101, "detail": { "sa_score": 1.41 } } } }, { "label": "aspirin", "note": "결핵과 무관 (음성 대조)", "note_en": "nothing to do with tuberculosis (negative control)", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 0.724, "axes": { "activity": { "points": 0.263, "detail": { "pAct_q10": 3.11, "threshold_passed": false, "threshold_term": 0.017, "ramp_term": 0.009, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.17, "detail": { "pIC50": 3.92, "LE": 0.414, "potency_term": 0.007, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 3.7, "selectivity_term": 0.282, "target_engagement": 0.0 } }, "admet": { "points": 0.148, "detail": { "geometric_mean": 0.751, "per_endpoint": { "solubility-aqsoldb": 1.0, "caco2-wang": 0.997, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.117, "herg": 1.0, "dili": 1.0 } } }, "novelty": { "points": 0.077, "detail": { "max_tanimoto": 0.417, "novelty": 0.583 } }, "synthesis": { "points": 0.066, "detail": { "sa_score": 1.58 } } } }, { "label": "ethambutol", "note": "승인약이나 표준 시험에서 약하다", "note_en": "approved, but weak under standard testing", "admitted": true, "relegated": false, "relegate_reason": [], "tier": 1, "total": 0.556, "axes": { "activity": { "points": 0.214, "detail": { "pAct_q10": 3.027, "threshold_passed": false, "threshold_term": 0.014, "ramp_term": 0.007, "tau": 3.8131, "ramp": [ 4.0712, 5.1512 ] } }, "binding": { "points": 0.208, "detail": { "pIC50": 4.01, "LE": 0.392, "potency_term": 0.008, "efficiency_cap": 1.0, "heavy_halogens": 0, "halogen_correction": 1.0 } }, "selectivity": { "points": 0.0, "detail": { "fold": 1.2, "selectivity_term": 0.046, "target_engagement": 0.0 } }, "admet": { "points": 0.091, "detail": { "geometric_mean": 0.569, "per_endpoint": { "solubility-aqsoldb": 1.0, "caco2-wang": 0.293, "hia-hou": 1.0, "bioavailability-ma": 1.0, "pgp-broccatelli": 1.0, "cyp2c9-veith": 1.0, "cyp3a4-substrate-carbonmangels": 1.0, "ld50-zhu": 0.05, "herg": 1.0, "dili": 1.0 } } }, "novelty": { "points": 0.0, "detail": { "max_tanimoto": 1.0, "novelty": 0.0 } }, "synthesis": { "points": 0.043, "detail": { "sa_score": 3.21 } } } } ]